Kenneth A. Lock

Companies

• Arcutis Biotherapeutics, Inc.Chief Commercial Officer Jan 30, 2020 to Mar 8, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABArcutis Biotherapeutics, Inc. ARQT63,429 shares²$2.1M at $32.50Mar 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 6, 2023Sold 831 shares at $15.26 of Arcutis Biotherapeutics, Inc.²
• Mar 2, 2023Sold 18 shares at $16.52 of Arcutis Biotherapeutics, Inc.³
• Mar 2, 2023Sold 1,414 shares at $15.82 of Arcutis Biotherapeutics, Inc.³
• Mar 2, 2023Granted 21,000 shares of Arcutis Biotherapeutics, Inc.⁴
• Feb 28, 2023Sold 936 shares at $16.17 of Arcutis Biotherapeutics, Inc.³
• Mar 7, 2022Sold 30 shares at $16.44 of Arcutis Biotherapeutics, Inc.⁵
• Mar 4, 2022Sold 993 shares at $16.86 of Arcutis Biotherapeutics, Inc.⁵
• Mar 3, 2022Granted 13,300 shares of Arcutis Biotherapeutics, Inc.⁵
• Mar 1, 2022Sold 935 shares at $17.75 of Arcutis Biotherapeutics, Inc.⁶